First FDA approved immunotherapy for Merkel cell carcinoma implemented in locations worldwide
November 13, 2017
Authorization for BAVENCIO® (avelumab) as a monotherapy for the treatment of adult patients with metastatic Merkel cell carcinoma (mMCC) has been granted in several locations worldwide.
Updates on avelumab approvals:
- United States — March 23, 2017
- Switzerland — September 5, 2017
- European Union (+ Norway, Liechtenstein and Iceland) — September 21, 2017
- Japan — September 27, 2017
The authoritative source on Merkel cell carcinoma.
Last updated:
March 24, 2024
About the Disease
- What is a Merkel cell?
- What is Merkel cell carcinoma?
- Symptoms & appearance of Merkel cell carcinoma
- Causes of Merkel cell carcinoma
Testing & Diagnosis
Created in partnership with:
Seattle Multidisciplinary MCC Team, University of Washington MCC Research, and Fred Hutchinson Cancer Center.